DELTERA HEALTHTECH LTD

Company Registration Number:
13907524 (England and Wales)

Unaudited abridged accounts for the year ended 28 February 2023

Period of accounts

Start date: 10 February 2022

End date: 28 February 2023

DELTERA HEALTHTECH LTD

Contents of the Financial Statements

for the Period Ended 28 February 2023

Balance sheet
Notes

DELTERA HEALTHTECH LTD

Balance sheet

As at 28 February 2023


Notes

13 months to 28 February 2023


£
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks: 0
Debtors:   0
Cash at bank and in hand: 982
Investments:   0
Total current assets: 982
Creditors: amounts falling due within one year:   (13,447)
Net current assets (liabilities): (12,465)
Total assets less current liabilities: (12,465)
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Total net assets (liabilities): (12,465)
Capital and reserves
Called up share capital: 100
Profit and loss account: (12,565)
Shareholders funds: (12,465)

The notes form part of these financial statements

DELTERA HEALTHTECH LTD

Balance sheet statements

For the year ending 28 February 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 04 November 2023
and signed on behalf of the board by:

Name: Daniel Stephen Wright
Status: Director

The notes form part of these financial statements

DELTERA HEALTHTECH LTD

Notes to the Financial Statements

for the Period Ended 28 February 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

The turnover represents amounts receivable for goods and services net of VAT and trade discounts

Tangible fixed assets and depreciation policy

Annual depreciation of computer equipment is calculated at 25% of cost to write off the cost of the asset, less its residual value, over its estimated useful economic lifetime

Intangible fixed assets and amortisation policy

Annual amortisation of goodwill is calculated at 25% to write off the cost of the asset, minus its residual value, over its estimated useful lifetime

DELTERA HEALTHTECH LTD

Notes to the Financial Statements

for the Period Ended 28 February 2023

2. Employees

13 months to 28 February 2023
Average number of employees during the period 0